| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0041 | 1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.0039 | 1 |